30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Biomimetic Therapeutics LLC (BMTI)

Track

Stock chart
Ticker: BMTI
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Friedlaender Gary E
1 purchase — total 27,923 USD
Buy 2 Apr 2012
Value US$130,151.87 | Price 69.60 | Shares 99,118
Buy 30 Mar 2012
Value US$3,715,011.97 | Price 427.18 | Shares 3,862
Buy 30 Mar 2012
Value US$2,055,711.95 | Price 246.46 | Shares 51,566
Buy 29 Mar 2012
Value US$72,890.87 | Price 2.38 | Shares 30,638
Sale 28 Mar 2012
Value US$18,822.40 | Price 2.35 | Shares 8,000
Sale 28 Mar 2012
Value US$1,093.03 | Price 2.37 | Shares 461
Sale 28 Mar 2012
Value US$11,910.00 | Price 2.38 | Shares 5,000
Sale 28 Mar 2012
Value US$11,850.00 | Price 2.37 | Shares 5,000
Sale 28 Mar 2012
Value US$4,720.20 | Price 2.36 | Shares 2,000
Sale 28 Mar 2012
Value US$705.00 | Price 2.35 | Shares 300
Sale 28 Mar 2012
Value US$940.00 | Price 2.35 | Shares 400
Sale 28 Mar 2012
Value US$3,055.00 | Price 2.35 | Shares 1,300
Sale 28 Mar 2012
Value US$11,800.00 | Price 2.36 | Shares 5,000
Sale 28 Mar 2012
Value US$7,023.90 | Price 2.34 | Shares 3,000
Sale 28 Mar 2012
Value US$14,100.00 | Price 2.35 | Shares 6,000
Sale 28 Mar 2012
Value US$3,262.00 | Price 2.33 | Shares 1,400
Sale 28 Mar 2012
Value US$7,722.33 | Price 2.34 | Shares 3,300
Sale 28 Mar 2012
Value US$466.00 | Price 2.33 | Shares 200
Sale 28 Mar 2012
Value US$2,552.00 | Price 2.32 | Shares 1,100
Sale 28 Mar 2012
Value US$11,750.00 | Price 2.35 | Shares 5,000
Buy 27 Mar 2012
Value US$5,606.40 | Price 2.34 | Shares 2,400
Buy 27 Mar 2012
Value US$6,951.00 | Price 2.32 | Shares 3,000
Buy 27 Mar 2012
Value US$6,954.00 | Price 2.32 | Shares 3,000
Buy 27 Mar 2012
Value US$4,636.00 | Price 2.32 | Shares 2,000
Sale 27 Mar 2012
Value US$11,700.00 | Price 2.34 | Shares 5,000
Sale 26 Mar 2012
Value US$2,585.00 | Price 2.35 | Shares 1,100
Buy 23 Mar 2012
Value US$1,057.50 | Price 2.35 | Shares 450
Buy 23 Mar 2012
Value US$6,345.00 | Price 2.35 | Shares 2,700
Buy 23 Mar 2012
Value US$23,500.00 | Price 2.35 | Shares 10,000
Buy 20 Mar 2012
Value US$38,874.00 | Price 2.20 | Shares 17,670
Buy 19 Mar 2012
Value US$10,948.50 | Price 2.19 | Shares 5,000
Buy 19 Mar 2012
Value US$10,920.50 | Price 2.18 | Shares 5,000
Buy 19 Mar 2012
Value US$10,983.50 | Price 2.20 | Shares 5,000
Buy 19 Mar 2012
Value US$5,126.00 | Price 2.20 | Shares 2,330
Planned sale 14 Oct 2011
Value US$9,166.50 | Price 3.06 | Shares 3,000
Planned sale 13 Oct 2011
Value US$8,941.50 | Price 2.98 | Shares 3,000
Planned sale 11 Oct 2011
Value US$9,015.60 | Price 3.01 | Shares 3,000
Planned sale 10 Oct 2011
Value US$8,910.60 | Price 2.97 | Shares 3,000
Planned sale 7 Oct 2011
Value US$9,046.50 | Price 3.02 | Shares 3,000
Planned sale 5 Oct 2011
Value US$8,836.20 | Price 2.95 | Shares 3,000
Planned sale 4 Oct 2011
Value US$8,678.40 | Price 2.89 | Shares 3,000
Sale 10 Jun 2011
Value US$11,406.00 | Price 5.70 | Shares 2,000
Sale 10 Jun 2011
Value US$11,366.20 | Price 5.68 | Shares 2,000
Sale 10 Jun 2011
Value US$14,263.75 | Price 5.71 | Shares 2,500
Buy 18 May 2011
Value US$23,250.00 | Price 7.75 | Shares 3,000
Buy 15 Jul 2010
Value US$8,500,000.00 | Price 8.50 | Shares 1,000,000
Sale 17 Mar 2010
Value US$7,581.51 | Price 13.30 | Shares 570
Sale 17 Mar 2010
Value US$58,919.00 | Price 13.30 | Shares 4,430
Planned sale 13 Jan 2010
Value US$3,629.89 | Price 12.14 | Shares 299
Planned sale 13 Jan 2010
Value US$151,250.00 | Price 12.10 | Shares 12,500
Sale 29 Dec 2009
Value US$33,870.00 | Price 11.29 | Shares 3,000
Sale 28 Dec 2009
Value US$34,680.00 | Price 11.56 | Shares 3,000
Sale 15 Dec 2009
Value US$36,090.00 | Price 12.03 | Shares 3,000
Sale 14 Dec 2009
Value US$36,960.00 | Price 12.32 | Shares 3,000
Sale 3 Dec 2009
Value US$33,720.00 | Price 11.24 | Shares 3,000
Sale 2 Dec 2009
Value US$32,820.00 | Price 10.94 | Shares 3,000
Sale 17 Nov 2009
Value US$34,920.00 | Price 11.64 | Shares 3,000
Sale 16 Nov 2009
Value US$35,400.00 | Price 11.80 | Shares 3,000
Sale 5 Nov 2009
Value US$35,100.00 | Price 11.70 | Shares 3,000
Sale 4 Nov 2009
Value US$34,890.00 | Price 11.63 | Shares 3,000
Sale 21 Oct 2009
Value US$20,775.00 | Price 13.85 | Shares 1,500
Sale 21 Oct 2009
Value US$41,550.00 | Price 13.85 | Shares 3,000
Sale 20 Oct 2009
Value US$21,315.00 | Price 14.21 | Shares 1,500
Sale 20 Oct 2009
Value US$42,660.00 | Price 14.22 | Shares 3,000
Sale 6 Oct 2009
Value US$37,723.80 | Price 12.57 | Shares 3,000
Sale 6 Oct 2009
Value US$18,842.55 | Price 12.56 | Shares 1,500
Sale 5 Oct 2009
Value US$34,513.80 | Price 11.50 | Shares 3,000
Planned sale 24 Sep 2009
Value US$19,475.25 | Price 12.98 | Shares 1,500
Planned sale 24 Sep 2009
Value US$38,958.00 | Price 12.99 | Shares 3,000
Planned sale 23 Sep 2009
Value US$19,672.50 | Price 13.12 | Shares 1,500
Planned sale 10 Sep 2009
Value US$35,983.20 | Price 11.99 | Shares 3,000
Planned sale 26 Aug 2009
Value US$34,402.80 | Price 11.47 | Shares 3,000
Planned sale 13 Aug 2009
Value US$32,376.00 | Price 10.79 | Shares 3,000
Planned sale 30 Jul 2009
Value US$1,029.00 | Price 10.29 | Shares 100
Planned sale 30 Jul 2009
Value US$1,022.00 | Price 10.22 | Shares 100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2012-04-04 2012-04-02 B Purchase Friedlaender Gary E Non-Executive Director
99,118 +47.1%
69.60
US$130,152 		99,118 +47.1% 69.60 US$130,152
2012-03-30 2012-03-30 B Purchase Lynch Samuel Eugene

President and CEO

Executive Director
3,862 +44.5%
427.18
US$3,715,012 		3,862 +44.5% 427.18 US$3,715,012
2012-03-30 2012-03-30 B Purchase Lynch Samuel Eugene

President and CEO

Executive Director
51,566 +29.4%
246.46
US$2,055,712 		51,566 +29.4% 246.46 US$2,055,712
2012-03-30 2012-03-29 B Purchase Lynch Samuel Eugene

President and CEO

Executive Director
30,638 +2.6%
2.38
US$72,891 		30,638 +2.6% 2.38 US$72,891
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
8,000 -42.0%
2.35
US$18,822 		8,000 -42.0% 2.35 US$18,822
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
461 -2.4%
2.37
US$1,093 		461 -2.4% 2.37 US$1,093
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
5,000 -20.4%
2.38
US$11,910 		5,000 -20.4% 2.38 US$11,910
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
5,000 -16.9%
2.37
US$11,850 		5,000 -16.9% 2.37 US$11,850
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
2,000 -6.3%
2.36
US$4,720 		2,000 -6.3% 2.36 US$4,720
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
300 -0.9%
2.35
US$705 		300 -0.9% 2.35 US$705
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
400 -1.2%
2.35
US$940 		400 -1.2% 2.35 US$940
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
1,300 -3.9%
2.35
US$3,055 		1,300 -3.9% 2.35 US$3,055
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
5,000 -13.0%
2.36
US$11,800 		5,000 -13.0% 2.36 US$11,800
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
3,000 -7.2%
2.34
US$7,024 		3,000 -7.2% 2.34 US$7,024
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
6,000 -12.6%
2.35
US$14,100 		6,000 -12.6% 2.35 US$14,100
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
1,400 -2.9%
2.33
US$3,262 		1,400 -2.9% 2.33 US$3,262
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
3,300 -6.3%
2.34
US$7,722 		3,300 -6.3% 2.34 US$7,722
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
200 -0.4%
2.33
US$466 		200 -0.4% 2.33 US$466
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
1,100 -2.1%
2.32
US$2,552 		1,100 -2.1% 2.32 US$2,552
2012-03-28 2012-03-28 S Sale Douglas Earl Martin

General Counsel

Officer
5,000 -8.5%
2.35
US$11,750 		5,000 -8.5% 2.35 US$11,750
2012-03-29 2012-03-27 B Purchase PAPASAN LARRY W Non-Executive Director
2,400 +8.5%
2.34
US$5,606 		2,400 +8.5% 2.34 US$5,606
2012-03-29 2012-03-27 B Purchase PAPASAN LARRY W Non-Executive Director
3,000 +11.8%
2.32
US$6,951 		3,000 +11.8% 2.32 US$6,951
2012-03-29 2012-03-27 B Purchase PAPASAN LARRY W Non-Executive Director
3,000 +13.4%
2.32
US$6,954 		3,000 +13.4% 2.32 US$6,954
2012-03-29 2012-03-27 B Purchase PAPASAN LARRY W Non-Executive Director
2,000 +9.8%
2.32
US$4,636 		2,000 +9.8% 2.32 US$4,636
2012-03-28 2012-03-27 S Sale Douglas Earl Martin

General Counsel

Officer
5,000 -7.9%
2.34
US$11,700 		5,000 -7.9% 2.34 US$11,700
2012-03-28 2012-03-26 S Sale Douglas Earl Martin

General Counsel

Officer
1,100 -1.7%
2.35
US$2,585 		1,100 -1.7% 2.35 US$2,585
2012-03-28 2012-03-23 B Purchase Lynch Samuel Eugene

President and CEO

Executive Director
450 +8.8%
2.35
US$1,058 		450 +8.8% 2.35 US$1,058
2012-03-28 2012-03-23 B Purchase Lynch Samuel Eugene

President and CEO

Executive Director
2,700 +0.2%
2.35
US$6,345 		2,700 +0.2% 2.35 US$6,345
2012-03-28 2012-03-23 B Purchase Lynch Samuel Eugene

President and CEO

Executive Director
10,000 +0.9%
2.35
US$23,500 		10,000 +0.9% 2.35 US$23,500
2012-03-21 2012-03-20 B Purchase BULLOCK LAWRENCE E

Chief Financial Officer

Officer
17,670 +28.9%
2.20
US$38,874 		17,670 +28.9% 2.20 US$38,874
2012-03-21 2012-03-19 B Purchase Friedlaender Gary E Non-Executive Director
5,000 +73.9%
2.19
US$10,948 		5,000 +73.9% 2.19 US$10,948
2012-03-21 2012-03-19 B Purchase Friedlaender Gary E Non-Executive Director
5,000 +50.5%
2.18
US$10,920 		5,000 +50.5% 2.18 US$10,920
2012-03-21 2012-03-19 B Purchase BULLOCK LAWRENCE E

Chief Financial Officer

Officer
2,330 +4.0%
2.20
US$5,126 		2,330 +4.0% 2.20 US$5,126
2012-03-21 2012-03-19 B Purchase Friedlaender Gary E Non-Executive Director
5,000 +17.2%
2.20
US$10,984 		5,000 +17.2% 2.20 US$10,984
2011-10-14 2011-10-14 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
3,000 -5.0%
3.06
US$9,166 		3,000 -5.0% 3.06 US$9,166
2011-10-14 2011-10-13 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
3,000 -4.8%
2.98
US$8,942 		3,000 -4.8% 2.98 US$8,942
2011-10-11 2011-10-11 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
3,000 -4.3%
3.01
US$9,016 		3,000 -4.3% 3.01 US$9,016
2011-10-11 2011-10-10 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
3,000 -4.2%
2.97
US$8,911 		3,000 -4.2% 2.97 US$8,911
2011-10-11 2011-10-07 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
3,000 -4.0%
3.02
US$9,046 		3,000 -4.0% 3.02 US$9,046
2011-10-05 2011-10-05 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
3,000 -3.7%
2.95
US$8,836 		3,000 -3.7% 2.95 US$8,836
2011-10-05 2011-10-04 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
3,000 -3.6%
2.89
US$8,678 		3,000 -3.6% 2.89 US$8,678
2011-06-14 2011-06-10 S Sale PAPASAN LARRY W Non-Executive Director
2,000 -8.9%
5.70
US$11,406 		2,000 -8.9% 5.70 US$11,406
2011-06-14 2011-06-10 S Sale PAPASAN LARRY W Non-Executive Director
2,000 -8.2%
5.68
US$11,366 		2,000 -8.2% 5.68 US$11,366
2011-06-14 2011-06-10 S Sale PAPASAN LARRY W Non-Executive Director
2,500 -9.3%
5.71
US$14,264 		2,500 -9.3% 5.71 US$14,264
2011-05-19 2011-05-18 B Purchase Lynch Samuel Eugene

President and CEO

Executive Director
3,000 +0.3%
7.75
US$23,250 		3,000 +0.3% 7.75 US$23,250
2010-07-19 2010-07-15 B Purchase Novo A/S Large shareholder
1,000,000 +26.9%
8.50
US$8,500,000 		1,000,000 +26.9% 8.50 US$8,500,000
2010-03-19 2010-03-17 S Sale Douglas Earl Martin

General Counsel

Officer
570 -0.7%
13.30
US$7,582 		570 -0.7% 13.30 US$7,582
2010-03-19 2010-03-17 S Sale Douglas Earl Martin

General Counsel

Officer
4,430 -5.1%
13.30
US$58,919 		4,430 -5.1% 13.30 US$58,919
2010-01-14 2010-01-13 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
299 -0.9%
12.14
US$3,630 		299 -0.9% 12.14 US$3,630
2010-01-14 2010-01-13 PlS Planned sale Douglas Earl Martin

General Counsel

Officer
12,500 -28.2%
12.10
US$151,250 		12,500 -28.2% 12.10 US$151,250
2009-12-30 2009-12-29 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.4%
11.29
US$33,870 		3,000 -0.4% 11.29 US$33,870
2009-12-30 2009-12-28 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.4%
11.56
US$34,680 		3,000 -0.4% 11.56 US$34,680
2009-12-16 2009-12-15 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.4%
12.03
US$36,090 		3,000 -0.4% 12.03 US$36,090
2009-12-16 2009-12-14 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.4%
12.32
US$36,960 		3,000 -0.4% 12.32 US$36,960
2009-12-04 2009-12-03 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.4%
11.24
US$33,720 		3,000 -0.4% 11.24 US$33,720
2009-12-04 2009-12-02 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.4%
10.94
US$32,820 		3,000 -0.4% 10.94 US$32,820
2009-11-18 2009-11-17 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
11.64
US$34,920 		3,000 -0.3% 11.64 US$34,920
2009-11-18 2009-11-16 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
11.80
US$35,400 		3,000 -0.3% 11.80 US$35,400
2009-11-06 2009-11-05 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
11.70
US$35,100 		3,000 -0.3% 11.70 US$35,100
2009-11-06 2009-11-04 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
11.63
US$34,890 		3,000 -0.3% 11.63 US$34,890
2009-10-23 2009-10-21 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
1,500 -0.2%
13.85
US$20,775 		1,500 -0.2% 13.85 US$20,775
2009-10-23 2009-10-21 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
13.85
US$41,550 		3,000 -0.3% 13.85 US$41,550
2009-10-23 2009-10-20 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
1,500 -0.2%
14.21
US$21,315 		1,500 -0.2% 14.21 US$21,315
2009-10-23 2009-10-20 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
14.22
US$42,660 		3,000 -0.3% 14.22 US$42,660
2009-10-07 2009-10-06 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
12.57
US$37,724 		3,000 -0.3% 12.57 US$37,724
2009-10-07 2009-10-06 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
1,500 -0.2%
12.56
US$18,843 		1,500 -0.2% 12.56 US$18,843
2009-10-07 2009-10-05 S Sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
11.50
US$34,514 		3,000 -0.3% 11.50 US$34,514
2009-09-25 2009-09-24 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
1,500 -0.2%
12.98
US$19,475 		1,500 -0.2% 12.98 US$19,475
2009-09-25 2009-09-24 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
12.99
US$38,958 		3,000 -0.3% 12.99 US$38,958
2009-09-25 2009-09-23 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
1,500 -0.2%
13.12
US$19,672 		1,500 -0.2% 13.12 US$19,672
2009-09-11 2009-09-10 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
11.99
US$35,983 		3,000 -0.3% 11.99 US$35,983
2009-08-27 2009-08-26 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
11.47
US$34,403 		3,000 -0.3% 11.47 US$34,403
2009-08-14 2009-08-13 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
3,000 -0.3%
10.79
US$32,376 		3,000 -0.3% 10.79 US$32,376
2009-07-31 2009-07-30 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
100 -0.0%
10.29
US$1,029 		100 -0.0% 10.29 US$1,029
2009-07-31 2009-07-30 PlS Planned sale Lynch Samuel Eugene

President and CEO

Executive Director
100 -0.0%
10.22
US$1,022 		100 -0.0% 10.22 US$1,022
Explore more

More insider trading research around Biomimetic Therapeutics LLC

More insider trades in United States
Insider trading in North America